circZKSCAN1 encodes circZKSaa, which plays a tumor-inhibiting role in the PI3K/AKT/mTOR pathway and sensitizes HCC cells to the first-line drug sorafenib by mediating the ubiquitination of mTOR to inhibit HCC development.52 This evidence concerns the gene AKT1 and hepatocellular carcinoma.